Cargando…
Remission of lupus nephritis: the trajectory of histological response in successfully treated patients
OBJECTIVE: This study investigated changes in kidney histology over time in patients with lupus nephritis (LN) undergoing immunosuppressive treatment. METHODS: Patients with proliferative±membranous LN were studied. After a diagnostic kidney biopsy (Bx1), patients had protocol biopsy 2 (Bx2) at 9 (6...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255076/ https://www.ncbi.nlm.nih.gov/pubmed/37258036 http://dx.doi.org/10.1136/lupus-2023-000932 |
_version_ | 1785056785584881664 |
---|---|
author | Malvar, Ana Alberton, Valeria Lococo, Bruno Lourenco, Maria Martinez, Joaquin Burna, Lucrecia Besso, Celeste Navarro, Jordi Nagaraja, Haikady N Khatiwada, Aastha Wolf, Bethany Rovin, Brad |
author_facet | Malvar, Ana Alberton, Valeria Lococo, Bruno Lourenco, Maria Martinez, Joaquin Burna, Lucrecia Besso, Celeste Navarro, Jordi Nagaraja, Haikady N Khatiwada, Aastha Wolf, Bethany Rovin, Brad |
author_sort | Malvar, Ana |
collection | PubMed |
description | OBJECTIVE: This study investigated changes in kidney histology over time in patients with lupus nephritis (LN) undergoing immunosuppressive treatment. METHODS: Patients with proliferative±membranous LN were studied. After a diagnostic kidney biopsy (Bx1), patients had protocol biopsy 2 (Bx2) at 9 (6–15) months and protocol biopsy 3 (Bx3) at 42 (28–67) months. Kidney histological activity and chronicity indices (AI, CI) were measured. RESULTS: AI declined in a biphasic fashion, falling rapidly between Bx1 and Bx2 and then more slowly between Bx2 and Bx3. Patients were divided into those who achieved histological remission, defined as an AI=0 at Bx3 (group 1), and those with persistent histological activity (AI >0) at Bx3 (group 2). The early decline in AI was 1.6 times greater (95% CI 1.30, 1.91) in group 1 than group 2 (p=0.01). Between Bx2 and Bx3, the AI decline was 2.19-fold greater (95% CI 2.09, 2.29) in group 1 versus group 2 (p=7.34×10(−5)). Individual histological components of the AI resolved at different rates. Inflammatory lesions like glomerular crescents, karyorrhexis and necrosis mostly resolved by Bx2, whereas endocapillary hypercellularity, subendothelial hyaline deposits and interstitial inflammation resolved slowly, accounting for residual histological activity at biopsy 3 in group 2. In contrast, CI increased rapidly, by 0.15 units/month between Bx1 and Bx2, then plateaued. There were no differences in the rate of accumulation of chronic damage between group 1 and group 2. The increase in CI was significantly related to the severity of glomerular crescents (p=0.044), subendothelial hyaline deposits (p=0.002) and interstitial inflammation (p=0.015) at Bx1. CONCLUSIONS: LN histological activity takes months to years to resolve, providing a rationale for the need of long-term, well-tolerated maintenance immunosuppression. Despite responding, LN kidneys accrue chronic damage early during treatment. This finding provides an explanation for the association of chronic progressive kidney disease with recurrent episodes of LN. |
format | Online Article Text |
id | pubmed-10255076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-102550762023-06-10 Remission of lupus nephritis: the trajectory of histological response in successfully treated patients Malvar, Ana Alberton, Valeria Lococo, Bruno Lourenco, Maria Martinez, Joaquin Burna, Lucrecia Besso, Celeste Navarro, Jordi Nagaraja, Haikady N Khatiwada, Aastha Wolf, Bethany Rovin, Brad Lupus Sci Med Lupus Nephritis OBJECTIVE: This study investigated changes in kidney histology over time in patients with lupus nephritis (LN) undergoing immunosuppressive treatment. METHODS: Patients with proliferative±membranous LN were studied. After a diagnostic kidney biopsy (Bx1), patients had protocol biopsy 2 (Bx2) at 9 (6–15) months and protocol biopsy 3 (Bx3) at 42 (28–67) months. Kidney histological activity and chronicity indices (AI, CI) were measured. RESULTS: AI declined in a biphasic fashion, falling rapidly between Bx1 and Bx2 and then more slowly between Bx2 and Bx3. Patients were divided into those who achieved histological remission, defined as an AI=0 at Bx3 (group 1), and those with persistent histological activity (AI >0) at Bx3 (group 2). The early decline in AI was 1.6 times greater (95% CI 1.30, 1.91) in group 1 than group 2 (p=0.01). Between Bx2 and Bx3, the AI decline was 2.19-fold greater (95% CI 2.09, 2.29) in group 1 versus group 2 (p=7.34×10(−5)). Individual histological components of the AI resolved at different rates. Inflammatory lesions like glomerular crescents, karyorrhexis and necrosis mostly resolved by Bx2, whereas endocapillary hypercellularity, subendothelial hyaline deposits and interstitial inflammation resolved slowly, accounting for residual histological activity at biopsy 3 in group 2. In contrast, CI increased rapidly, by 0.15 units/month between Bx1 and Bx2, then plateaued. There were no differences in the rate of accumulation of chronic damage between group 1 and group 2. The increase in CI was significantly related to the severity of glomerular crescents (p=0.044), subendothelial hyaline deposits (p=0.002) and interstitial inflammation (p=0.015) at Bx1. CONCLUSIONS: LN histological activity takes months to years to resolve, providing a rationale for the need of long-term, well-tolerated maintenance immunosuppression. Despite responding, LN kidneys accrue chronic damage early during treatment. This finding provides an explanation for the association of chronic progressive kidney disease with recurrent episodes of LN. BMJ Publishing Group 2023-05-31 /pmc/articles/PMC10255076/ /pubmed/37258036 http://dx.doi.org/10.1136/lupus-2023-000932 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Lupus Nephritis Malvar, Ana Alberton, Valeria Lococo, Bruno Lourenco, Maria Martinez, Joaquin Burna, Lucrecia Besso, Celeste Navarro, Jordi Nagaraja, Haikady N Khatiwada, Aastha Wolf, Bethany Rovin, Brad Remission of lupus nephritis: the trajectory of histological response in successfully treated patients |
title | Remission of lupus nephritis: the trajectory of histological response in successfully treated patients |
title_full | Remission of lupus nephritis: the trajectory of histological response in successfully treated patients |
title_fullStr | Remission of lupus nephritis: the trajectory of histological response in successfully treated patients |
title_full_unstemmed | Remission of lupus nephritis: the trajectory of histological response in successfully treated patients |
title_short | Remission of lupus nephritis: the trajectory of histological response in successfully treated patients |
title_sort | remission of lupus nephritis: the trajectory of histological response in successfully treated patients |
topic | Lupus Nephritis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10255076/ https://www.ncbi.nlm.nih.gov/pubmed/37258036 http://dx.doi.org/10.1136/lupus-2023-000932 |
work_keys_str_mv | AT malvarana remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT albertonvaleria remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT lococobruno remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT lourencomaria remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT martinezjoaquin remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT burnalucrecia remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT bessoceleste remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT navarrojordi remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT nagarajahaikadyn remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT khatiwadaaastha remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT wolfbethany remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients AT rovinbrad remissionoflupusnephritisthetrajectoryofhistologicalresponseinsuccessfullytreatedpatients |